Pharmacovigilance Risk Assessment Committee (PRAC) published new recommendations subsequent to the Esmya referral
18/05/2018
Business related Regulatory Marketing authorization application Women's Healthcare PRODUCT - ESMYA API - ULIPRISTAL ACETATE